Wisconsin Bio News

Original article from the Wisconsin State Journal. By Judy Newman. Three Madison startups have landed cash, two of them in the health IT (information technology) field. Meanwhile, Monona-based SHINE has lined up office space in downtown Janesville, close to its future moly-99 plant, and gener8tor has an agreement to work with the University of Minnesota […]

By Kathleen Gallagher , Milwaukee Journal Sentinel  Promentis Pharmaceuticals Inc., a Milwaukee company developing compounds for the treatment of schizophrenia and other central nervous system disorders, has raised $8.7 million in equity funding, according to a filing with federal securities regulators. The funding is another in a string of venture capital investments in Wisconsin start-ups that have been […]

Read the full article from www.prweb.com here. OMERSET, NJ (PRWEB) OCTOBER 13, 2016 Catalent Pharma Solutions, a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced today that it has entered into an agreement with Moderna Therapeutics to support near-term clinical Good Manufacturing Practice (GMP) messenger […]

Read the full article from the Wisconsin State Journal here. By Judy Newman.   HealthX Ventures, a new venture capital fund aimed at investing in health technology startups, has finalized its first fund at more than $20 million. The fund was founded in early 2015 by Mark Bakken, co-founder and former CEO of Nordic Consulting, one […]

More collaboration, capital and “wins” are needed to build Wisconsin’s biohealth sector, company executives said at a panel Tuesday. Michael Barbouche, CEO of Forward Health Group, a population health company, said while companies may want to work together, they don’t always reach out or connect with other organizations. “A big challenge is that we kind […]

When a homegrown Madison tech company is acquired, it’s always hard to predict whether the local operations and jobs will survive — regardless of the promises made when the deal goes through. In the case of TomoTherapy, though, not only has production continued here, it has grown. Five years after the Madison medical device company […]